![Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7102e1_PfizerMIS-C_IMAGE_07Jan22_SOCIAL_1200x675.jpg?_=63592)
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
![B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 - eBioMedicine B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 - eBioMedicine](https://www.thelancet.com/cms/asset/2c6d62b2-c75e-47bc-8445-48fca6641b30/gr1.jpg)
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 - eBioMedicine
![Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021 | MMWR Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7020e3_UrbanVsRuralVaccination_IMAGE_Public_18May21_1200x627_V2-medium.jpg?_=90291)
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021 | MMWR
![A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-53493-8/MediaObjects/41598_2019_53493_Fig1_HTML.png)
A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports
![Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock | Nature Biomedical Engineering Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock | Nature Biomedical Engineering](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41551-021-00756-3/MediaObjects/41551_2021_756_Fig1_HTML.png)
Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock | Nature Biomedical Engineering
![Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease - ScienceDirect Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004221011871-fx1.jpg)
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease - ScienceDirect
Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs | PLOS ONE
![Vaccines | Free Full-Text | A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine Vaccines | Free Full-Text | A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine](https://pub.mdpi-res.com/vaccines/vaccines-08-00771/article_deploy/html/images/vaccines-08-00771-g001.png?1608191775)
Vaccines | Free Full-Text | A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
![Vaccine and vaccination as a part of human life: In view of COVID‐19 - K.B. - 2022 - Biotechnology Journal - Wiley Online Library Vaccine and vaccination as a part of human life: In view of COVID‐19 - K.B. - 2022 - Biotechnology Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7bfd96a7-13be-4555-b0e7-369ce406267e/biot202100188-gra-0001-m.png)
Vaccine and vaccination as a part of human life: In view of COVID‐19 - K.B. - 2022 - Biotechnology Journal - Wiley Online Library
![Animals | Free Full-Text | Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences Animals | Free Full-Text | Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences](https://pub.mdpi-res.com/animals/animals-11-02039/article_deploy/html/images/animals-11-02039-g001-550.jpg?1626163127)
Animals | Free Full-Text | Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences
![Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology](https://www.cell.com/cms/attachment/16eea0fb-dcd2-40d2-b4ec-f696c4f6f3a4/gr1.jpg)
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology
![Next-generation T cell–activating vaccination increases influenza virus mutation prevalence | Science Advances Next-generation T cell–activating vaccination increases influenza virus mutation prevalence | Science Advances](https://www.science.org/cms/10.1126/sciadv.abl5209/asset/34135321-b7e3-4042-ba92-716ee7ce08bf/assets/images/large/sciadv.abl5209-f1.jpg)